In a recent development, a U.S. bankruptcy judge dismissed Johnson & Johnson's proposed $10 billion talc settlement. This marks a third unsuccessful bankruptcy bid by the company to address more than 60,000 pending lawsuits. The judge criticized the proposal for insufficient support from those affected by cancer and for attempting to protect non-bankrupt entities, deeming the plan too defective to advance. Johnson & Johnson announced that it will not appeal this decision but intends to contest the talc-related lawsuits in court.